9 Meters Biopharma NMTR

$ 0.07 -42.97%

Quarterly report 2023-Q1
added 05-15-2023

9 Meters Biopharma Financial Statements 2011-2024 | NMTR

Annual Financial Statements 9 Meters Biopharma

	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
Market Cap	17.5 M	11.9 M	147 M	25.7 M	57.2 M	5.75 M	9.23 M	-	-	-	-	-
Shares	13 M	12.2 M	106 M	33.3 M	24.8 M	942 K	552 K	-	-	-	-	-
Historical Prices	1.35	0.979	0.859	0.557	2.31	6.1	17.5	-	-	-	-	-
Net Income	-43.8 M	-36.8 M	-61.5 M	-27 M	-24.2 M	-7.92 M	-6.21 M	-8.74 M	-11.1 M	-3.44 M	-	-
Revenue	-	-	-	-	-	1.88 M	4.06 M	8.27 M	11.3 M	3.44 M	-	-
Cost of Revenue	-	-	-	-	-	-	-	-	-	-	-	-
Gross Profit	-	-	-	-	-	-64 K	736 K	426 K	234 K	606 K	-	-
Operating Income	-42 M	-36.8 M	-60.9 M	-25.5 M	18.2 M	11.2 M	-5.94 M	-6.46 M	-	-	-	-
Interest Expense	2.67 M	47.2 K	4.05 M	1.83 M	6.15 M	436 K	825 K	1.38 M	-	-	-	-
EBITDA	-42 M	-36.8 M	-59.4 M	-24.3 M	-18.2 M	-6.54 M	-5.81 M	-6.41 M	-9.38 M	-3.36 M	-	-
Operating Expenses	42 M	36.8 M	60.9 M	24.3 M	18.2 M	6.6 M	6.68 M	6.89 M	6.91 M	3.97 M	-	-
General and Administrative Expenses	11 M	9.66 M	10.5 M	10.6 M	10.7 M	4.98 M	3.98 M	3.62 M	2.65 M	1.75 M	-	-

All numbers in USD currency

Quarterly Income Statement 9 Meters Biopharma

	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
Shares	13.6 M	13 M	13 M	259 M	12.9 M	12.9 M	12.7 M	250 M	211 M	205 M	142 M	78.6 M	41.2 M	39.5 M	35.9 M	34 M	27.3 M	26.1 M	25.8 M	25.7 M	21.2 M	11.9 M	31.5 M	11.9 M	11.9 M	779 M	6.91 M	3.75 M	3.75 M	3.7 M	3.29 K	3.08 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net Income	-13.9 M	-	-9.35 M	-11.1 M	-11.4 M	-	-13.5 M	-8.25 M	-5.43 M	-	-8.33 M	-44.6 M	-3.6 M	-	-9.22 M	-4.49 M	-4.43 M	-	-776 K	-4.22 M	-15 M	-	-11.6 M	-11.6 M	-11.6 M	-	-1.83 M	-1.24 M	-1.88 M	-	-1.47 M	-1.16 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cost of Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Gross Profit	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-70 K	-39 K	-47 K	-	92 K	430 K	47 K	-	532 K	86 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Income	-12.8 M	-	-8.72 M	-11.2 M	-11.4 M	-	-13.5 M	-8.26 M	-5.4 M	-	-6.3 M	-44.8 M	-4.96 M	-	-6.51 M	-6.12 M	4.31 M	-	-220 K	3.38 M	11.3 M	-	2.34 M	2.69 M	3.92 M	-	-2.36 M	-901 K	-1.63 M	-	-1.39 M	-1.06 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Interest Expense	753 K	-	847 K	-	304	-	1.97 K	1.15 K	44.1 K	-	2.12 M	1.02 M	573 K	-	472 K	432 K	427 K	-	1.04 M	894 K	3.66 M	-	111 K	99.5 K	71.6 K	-	25 K	339 K	252 K	-	75 K	99 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
EBITDA	-12.8 M	-	-8.71 M	-11.2 M	-11.4 M	-	-13.5 M	-8.26 M	-5.4 M	-	-6.29 M	-44.8 M	-4.95 M	-	-6.49 M	-6.11 M	4.32 M	-	-205 K	3.39 M	11.3 M	-	2.34 M	2.69 M	3.92 M	-	-2.27 M	-836 K	-1.6 M	-	-1.37 M	-1.06 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Expenses	12.8 M	-	8.72 M	11.2 M	11.4 M	-	13.5 M	8.26 M	5.4 M	-	6.3 M	44.8 M	4.96 M	-	6.51 M	6.12 M	4.31 M	-	-220 K	3.38 M	11.3 M	-	2.34 M	2.69 M	3.92 M	-	2.46 M	1.33 M	1.68 M	-	1.92 M	1.14 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
General and Administrative Expenses	2.99 M	-	2.42 M	3.65 M	3 M	-	2.39 M	2.55 M	2.21 M	-	1.89 M	5.66 M	1.67 M	-	2.56 M	3.05 M	3.11 M	-	1.57 M	2.13 M	4.97 M	-	1.97 M	1.56 M	2.58 M	-	1.85 M	675 K	992 K	-	1.32 M	492 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency